Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
40°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LSD Therapy
Recent news which mentions LSD Therapy
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers
MNMD
NEWS
Tags
Psychedelics
Biotech
Benzinga
From
Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
March 08, 2024
Tickers
MNMD
NEWS
Tags
Biotech
Price Target Increases
Psychedelics
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
News
MNMD
Legal
From
Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
Tags
Biotech
Psychedelics
2023 financial results
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
News
Generalized Anxiety Disorder
MNMD
From
Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
August 23, 2023
Tags
News
Federico Fellini
General
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Next/Generation Psychedelics
Psychedelics
PHRRF
From
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers
CMPS
MNMD
NUMIF
Tags
Markets
Cedar Clinical Research
News
From
Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
Tickers
MNMD
Tags
MNMD
Proxy fight
News
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Psychedelics
Generalized Anxiety Disorder
Psychedelic/Assisted Therapies
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
Market News
Guidance
LSD Therapy
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
News
University Hospital Basel
MNMD
From
Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
January 13, 2023
Tags
Benzinga
Markets
Cannabis
From
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
Tickers
AWKNF
CMND
CMPS
PSIL
Tags
Psychedelics
AWKNF
CMND
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
News
clinical trials
Earnings
From
Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Tickers
BLRZF
Tags
Markets
News
Benzinga
From
Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
September 27, 2022
Tickers
BETRF
Tags
U/S/ Patent and Trademark Office
Market News
Markets
From
Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
September 08, 2022
Tickers
MNMD
Tags
Biological Psychiatry
Benzinga
Cannabis
From
Benzinga
Connecting To Nature Through Psychedelics
April 17, 2022
Tickers
TECH
Tags
Psychedelics
LSD
contributors
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.